Physician profile
Barry A Jansen
NPI 1427123348
$2,500.24
in general payments reported to CMS, 2019-2025
12 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $248 · 2022: $509 · 2023: $239 · 2024: $674 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.23 | 2024-2025 | Krystexxa |
| Treace Medical Concepts, INC. | $366.82 | 2022-2025 | |
| Smith+Nephew, INC. | $353.23 | 2019-2024 | Oasis, Stravix, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $240.58 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $220.63 | 2019-2020 | |
| Tactile Systems Technology INC | $197.85 | 2025 | Nimbl, Flexitouch Plus |
| Zimmer Biomet Holdings, INC. | $137.60 | 2022 | |
| Royal Biologics, INC. | $126.83 | 2020 | |
| Paragon 28, INC. | $121.57 | 2022 | |
| Abbvie INC. | $121.55 | 2022 | |
| Integra Lifesciences Corporation | $118.32 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbott Laboratories | $95.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.